Physician profile
Paul Benedict Brown
NPI 1275943326
$22,409.96
in general payments reported to CMS, 2019-2025
17 companies · $4,928 in 2025
The $4,928 reported for 2025 was more than what 81% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $3,504 · 2021: $5,647 · 2022: $4,704 · 2023: $445 · 2024: $3,181 · 2025: $4,928.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,065 · Food and Beverage: $3,489.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,065.31 |
| Food and Beverage | $3,488.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seapearl East, INC | $7,373.00 | 2020-2024 | |
| Smith+Nephew, INC. | $7,258.32 | 2020-2025 | Novostitch, Healicoil, Acufex Meniscal Root Repair |
| Arthrex, INC. | $4,778.56 | 2021-2024 | |
| Stryker Corporation | $981.80 | 2020-2025 | Gamma, Mako, Iconix |
| Medical Device Business Services, INC. | $816.57 | 2021 | |
| Depuy Synthes Sales INC. | $338.90 | 2021-2023 | Na |
| Bioventus LLC | $251.40 | 2020-2025 | Durolane, L360 Thigh System |
| Ferring Pharmaceuticals INC. | $228.62 | 2020-2025 | Euflexxa |
| Miach Orthopaedics, INC. | $137.15 | 2022 | |
| Sanofi-Aventis U.S. LLC | $67.92 | 2021-2022 | |
| Boston Scientific Corporation | $53.48 | 2021 | |
| Innovation Technologies INC | $36.80 | 2022 | |
| Pacira Therapeutics, INC. | $26.40 | 2020 | |
| Molnlycke Health Care US, LLC | $19.59 | 2023 | Avance |
| Glaxosmithkline, LLC. | $15.00 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $14.38 | 2021 | |
| Vericel Corporation | $12.07 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.